SCHEMBL17359683

SCHEMBL17359683

CCCCOc1cc(OCCCC)c2c(c1)OC(c1ccc(O)c(O)c1)C(O)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.54
▸ BACE1 P56817 4/20 0.54
▸ CYP3A4 P08684 4/20 0.54
▸ GAA P10253 3/20 0.54
▸ HSD17B10 Q99714 3/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ MAPT P10636 3/20 0.54
▸ MAPK1 P28482 3/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ PKM P14618 2/20 0.54
▸ APEX1 P27695 2/20 0.54
▸ RECQL P46063 2/20 0.54
▸ ALPL P05186 2/20 0.54
▸ POLB P06746 2/20 0.54
▸ ALOX15 P16050 2/20 0.54
▸ PTGS1 P23219 2/20 0.54
▸ PTGS2 P35354 2/20 0.54
▸ APP P05067 1/20 0.54
▸ AMY1A P0DUB6 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14700160 0.94 CYP3A4 (0.54) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL14700159 0.91 CYP3A4 (0.59) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL13508839 0.91 KDM4E (0.64) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL13002360 0.90 CYP3A4 (0.62) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL14404263 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL8249233 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL8247946 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL8240944 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL13077184 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10
SCHEMBL13508834 0.89 CYP3A4 (0.56) KDM4EBACE1CYP3A4GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9556140-B2 Approach for synthesis of catechins SPHAERA PHARMA PVT. LTD. (IN) 2017-01-31 — — US disclosed
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS EPIRIUM BIO INC. 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368223-A1 NOVEL APPROACH FOR SYNTHESIS OF CATECHINS NQO1, COMT, NNMT KDM4E 2056/4885BACE1 1434/4885CYP3A4 144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback